Pages that link to "Q28282044"
Jump to navigation
Jump to search
The following pages link to The microbial contribution to human faecal mass (Q28282044):
Displaying 50 items.
- Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans (Q24541358) (← links)
- Gut flora in health and disease (Q28209082) (← links)
- Quantifying your body: a how-to guide from a systems biology perspective (Q28272991) (← links)
- Sources of airborne microorganisms in the built environment (Q28397267) (← links)
- Fermented Papaya Preparation Restores Age-Related Reductions in Peripheral Blood Mononuclear Cell Cytolytic Activity in Tube-Fed Patients (Q28468408) (← links)
- The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota (Q29616595) (← links)
- Laxative effects of partially defatted flaxseed meal on normal and experimental constipated mice (Q31050112) (← links)
- Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut (Q33256618) (← links)
- The diversity of coliphages and coliforms in horse feces reveals a complex pattern of ecological interactions (Q33294397) (← links)
- The effect of resistant starch on colon function in humans (Q33435949) (← links)
- Effect of resistant starch on fecal bulk and fermentation-dependent events in humans (Q33483930) (← links)
- Role of fermentable carbohydrate supplements with a low-protein diet in the course of chronic renal failure: experimental bases (Q33589759) (← links)
- An apical permeability barrier to NH3/NH4+ in isolated, perfused colonic crypts (Q33708169) (← links)
- Diet and antioxidant status (Q33763080) (← links)
- The microbial flora of the gastrointestinal tract and the cleaning of flexible endoscopes. (Q33843075) (← links)
- Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients (Q33858968) (← links)
- The contribution of the large intestine to energy supplies in man (Q34055329) (← links)
- Prokaryotic and eukaryotic diversity of the human gut. (Q34124324) (← links)
- Beneficial health effects of low-digestible carbohydrate consumption (Q34230596) (← links)
- Digestibility and bulking effect of ispaghula husks in healthy humans (Q34380614) (← links)
- Metabolism of dietary sulphate: absorption and excretion in humans (Q34394214) (← links)
- In vivo IgA coating of anaerobic bacteria in human faeces (Q34409405) (← links)
- Role of intestinal bacteria in nutrient metabolism (Q34450176) (← links)
- The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology (Q34488475) (← links)
- Comparison between the bacterial and oligosaccharide content of ileostomy effluent in subjects taking diets rich in refined or unrefined carbohydrate (Q34526126) (← links)
- Effect of changing transit time on colonic microbial metabolism in man. (Q34527412) (← links)
- Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. (Q34528521) (← links)
- Revised Estimates for the Number of Human and Bacteria Cells in the Body (Q34537872) (← links)
- Short-chain fatty acids: ready for prime time? (Q34551412) (← links)
- Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes (Q34662533) (← links)
- Phages in nature (Q35029210) (← links)
- Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. (Q35105259) (← links)
- Microbial activities and intestinal homeostasis: A delicate balance between health and disease (Q35119984) (← links)
- Acetaldehyde, microbes, and cancer of the digestive tract (Q35130665) (← links)
- Role of the Gastrointestinal Mucosa and Microflora in the Bioactivation of Dietary and Environmental Mutagens or Carcinogens (Q35188611) (← links)
- Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial (Q35203723) (← links)
- Structural changes in the gut microbiome of constipated patients (Q35215231) (← links)
- The role of dietary fibre in the human colon (Q35229032) (← links)
- Norfloxacin binds to human fecal material (Q35566005) (← links)
- Net digestive absorption and adaptive hyperphagia in adult short bowel patients (Q35596782) (← links)
- Characterization of the cellulolytic bacteria communities along the gastrointestinal tract of Chinese Mongolian sheep by using PCR-DGGE and real-time PCR analysis (Q35619857) (← links)
- Energy content of stools in normal healthy controls and patients with cystic fibrosis (Q35626618) (← links)
- Effects of different starch sources on Bacillus spp. in intestinal tract and expression of intestinal development related genes of weanling piglets (Q35645634) (← links)
- Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates (Q35662102) (← links)
- Neutral sugar composition and gravimetric yield of plant and bacterial fractions of feces. (Q35738782) (← links)
- Metagenomic Analysis of Crohn's Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers (Q35757493) (← links)
- Bacterial diversity in the human gut. (Q35835077) (← links)
- Low-residue and low-fiber diets in gastrointestinal disease management (Q35841215) (← links)
- Gene expression profiling in non-human primate jejunum, ileum and colon after total-body irradiation: a comparative study of segment-specific molecular and cellular responses (Q35847556) (← links)
- Levan Enhances Associated Growth of Bacteroides, Escherichia, Streptococcus and Faecalibacterium in Fecal Microbiota (Q35858563) (← links)